Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
346
Views
5
CrossRef citations to date
0
Altmetric
Short Communications

The anticancer activity of two glycosides from the leaves of Leea aequata L.

, , , , , , & ORCID Icon show all
Pages 5867-5871 | Received 17 Apr 2020, Accepted 05 Jul 2020, Published online: 27 Jul 2020
 

Abstract

Two compounds (7-O-methylmearnsitrin (7-OM) and roseoside A (RA) were identified and characterized from the leaves of Leea aequata (L. aequata) L. The cytotoxicity of 7-OM and RA on HeLa cells was performed using MTT. The 7-OM and RA showed significant inhibition of HeLa cell proliferation with an IC50 of 22 and 20 µg/mL, respectively when compared with the standard vincristin sulphate (VS) (IC50 of 15 µg/mL). Moreover, the 7-OM and RA significantly inhibit other cancer cells (HEK-293, H228, and H3122) when compared with the VS and the cytotoxic activity of the compounds might show through the induction of apoptosis. Strikingly, annexin-V and PI signals could barely be detected in control cells, while strong fluorescence densities were observed in response to treatment indicating that these compounds have capacity to induce HeLa cell apoptosis. Our results suggest that the anticancer activity of 7-OM and RA was due to the induction of apoptosis.

Acknowledgments

The authors wish to thank the National Herbarium, Dhaka, Bangladesh for identification of the plant. The authors also want to give thank School of Pharmaceutical Sciences, College of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, 920-1192, Japan for purifying the compounds and taking 1H and 13C-NMR data as well as mass data. The authors want to give thank JASSO for giving follow up research grant at JAIST, Japan.

Disclosure statement

The author(s) declare(s) that there is no conflict of interests regarding the publication of this article.

Additional information

Funding

The authors declare that they have no fund for this study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.